Biography
Emili Montserrat is a professor at the European School of Hematology and the European School of Oncology. According to independent sources (International Citation Index, Utrecht University) Prof. Dr. Emili Montserrat is one of the most prestigious specialists worldwide in leukemia and lymphoma, and one of the most cited and renowned Spanish physicians. He is one of the founding members of the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) and the European Research Initiative for CLL (ERIC) of which he is the current president. He is also an expert on leukemia’s and lymphomas for the World Health Organization (WHO) and is a member of the most important hematological and oncological societies, such as the European Society of Medical Oncology, the American Society of Oncology and the American Society of Hematology. He has contributed more than 500 articles and 50 book chapters on hemato-oncology. He has been awarded distinctions and recognition for his scientific work, such as the Severo Ochoa Prize, the Lilly Foundation Award for Clinical Medicine, the EmiramEldor Medal (Israel) as well as the recognition of Distinguished Researcher from the University of Barcelona.
Research Interest
Emili Montserrat’s main areas of interest are Chronic Lymphoproliferative Disorders and Lymphoma.
Related Publications
-
Evaluation of Anticoagulant and Antiplatelet Activity of Pisum sativum Pod Extract
Research Article: J Blood Res Hematol Dis 2017, 2:1
DOI:
Chethana Ramachandraiah, Sharath Kumar M Nandish, Jayanna Kengaiah, Ashwini Shivaiah, Chandramma, Kesturu S.Girish, Kempaiah Kemparaju and Devaraja Sannaningaiah
-
Haemophilia B PMS1 Gene SNPs Predictions through Insilico Approach at Proteomics Levels
Research Article: J Blood Res Hematol Dis 2017, 2:1
DOI:
Hiba Siddig Ibrahim
-
Optimal Therapy for Polycythemia Vera and Essential Thrombocythemia: A Different Perspective
Editorial: J Blood Res Hematol Dis 2015, 1:1
DOI:
Richard T Silver and Hans Carl Hasselbalch
-
Recent Advances in Hodgkin Lymphoma
Editorial: J Blood Res Hematol Dis 2016, 1:2
DOI:
Theodoros P Vassilakopoulos and Sotirios G Papageorgiou
-
Characterization of Complex Chromosomal Rearrangements in Acute Myeloid Leukemia: FISH and Multicolor FISH Add Precision in Defining Abnormalities Associated with Poor Prognosis
Research Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Pina J Trivedi, Dharmesh M Patel, Manisha M Brahmbhatt and Prabhudas S Patel
-
Caring for a Sick Child
Editorial: J Blood Res Hematol Dis 2016, 1:1
DOI:
Luisa M Massimo
-
Relationship between Cellular Senescence and Redox Potential on Adult T-Cell Leukemia Cells
Short Communication: J Blood Res Hematol Dis 2016, 1:1
DOI:
Yasuhiro Maeda, Atsushi Okamoto, Shin-ichiro Kawaguchi, Akiko Konishi, Kenta Yamamoto, Go Eguchi and Terufumi Yamaguchi
-
EHPVO and Splanchnic Vein Thrombosis
Review Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Afaq Ahmad Khan, Zeeshan Ahmad Wani, Tufeel Kochak and Sonmoon Mohapatra
-
Autoimmune Thyroid Disease in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms Treated with Interferon-Alpha
Research Article: J Blood Res Hematol Dis 2016, 1:1
DOI:
Cecilie Paulsrud, Hans C Hasselbalch and Ole Weis Bjerrum
-
Efficiency of Pre-Storage Leukoreduction of Red Cells: A Double Blind Quality Control Method, Transfusion medicine
Letter to Editor: J Blood Res Hematol Dis 2016, 1:2
DOI:
Setia Rasika, Arora Satyam, Handoo Anil and Kapoor Meenu
-
Timely Dosage Dependent Ethanolic Extract of Mangifera Indica Promotes Blood Cells Development and Weight Gain
Research Article: J Blood Res Hematol Dis 2016, 1:2
DOI:
Jimmy EO and Udo ES
-
The Role of Wnt/β -Catenin Signaling in Normal and Malignant Hematopoiesis, Hemostasis
Review Article: J Blood Res Hematol Dis 2016, 1:1
DOI:
Teresa Sadras, Richard J D’Andrea and Deborah L White